Neutral Protamine Hagedorn (NPH) insulin
- Generic Name
- Neutral Protamine Hagedorn (NPH) insulin
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 503621-56-5
- Unique Ingredient Identifier
- -
- Associated Conditions
- -
- Associated Therapies
- -
Insulin Therapy for Post-transplant Glucocorticoid Induced Hyperglycemia
Phase 4
Terminated
- Conditions
- Interventions
- First Posted Date
- 2012-07-24
- Last Posted Date
- 2015-12-09
- Lead Sponsor
- Vancouver General Hospital
- Target Recruit Count
- 5
- Registration Number
- NCT01648218
- Locations
- 🇨🇦
Vancouver General Hospital - Jim Pattison Pavilion, Vancouver, British Columbia, Canada
6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 Diabetes
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-10-12
- Last Posted Date
- 2012-06-27
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 125
- Registration Number
- NCT00993473
- Locations
- 🇮🇳
Sanofi-Aventis Investigational Site Number 356001, Bangalore, India
🇮🇳Sanofi-Aventis Investigational Site Number 356004, Karnal, India
🇲🇽Sanofi-Aventis Investigational Site Number 484003, Monterrey, Mexico
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath